MDT diagnosis and treatment of a stage ⅢC lung squamous cell carcinoma case presented as superior sulcus tumor

Kaixuan Wang,Hong Jian,Qingquan Luo,Xuwei Cai,Changxing Lv,Yongfeng Yu,Jikai Zhao,Yifeng Jiang,Meilin Liao,Shun Lu

DOI: https://doi.org/10.13267/j.cnki.syzlzz.2018.01.004

2018-01-01

Abstract:This article describes the process of multidisciplinary team (MDT) diagnosis and treatment of a stage ⅢC lung squamous cell carcinoma case presented as superior sulcus tumor.A 68-year old female arrived for the first visit with a chief complaint of right shoulder pain accompanied with decreased right upper limb grip for one month.Chest CT suggested superior sulcus tumor at the right upper lobe of the lung.The pathological test of lung biopsy showed poorly differentiated lung squamous cell carcinoma.The adjacent ribs,the right subclavian artery,and phrenic nerve were involved,with suspicious metastasis of the right supraclavicular lymph node.The initial staging was c-T4N3 (suspicious)M0,stage ⅢC(suspicious).After the first MDT discussion,the treatment strategy was designed as induction therapy followed by resection.The patient received induction chemotherapy of gemcitabine combined with cisplatin for two cycles.The size of the right upper lobe tumor remained unchanged,but the right supraclavicular lymph node was reduced by 20％.The total effect was stable disease(SD).Subsequently,a second MDT discussion was conducted and concluded that the tumor reduction was insignificant by induction chemotherapy alone,and concurrent chemoradiotherapy is necessary.The patient was then switched to induction treatment of concurrent chemoradiotherapy,with two cycles of etoposide and cisplatin combined chemotherapy,together with radiotherapy which was given to the right upper lung mass and the right supraclavicular metastatic lymph node,with a dose of 46 Gy/23 fractions.After the chemoradiotherapy,the right upper lung tumor shrank 19％,with massive necrosis and empty formation.The right supraclavicular enlarged lymph node was reduced to less than 1 cm.The total effect was partial response(PR),re-staged as yc-T4NxM0,stage ⅢA.Afterwards,a third MDT discussion was organized and assessed the patient as Nx Pancoast tumor patient after concurrent chemoradiotherapy,who will be benefited significantly from complete (R0) resection.Since the patient also has diabetes,she received a video-assisted thoracoscopic (VATS) wedge resection of right upper lobe tumor,as well as the resection of the first right rib by right anterior L-shaped approach.Mediastinal lymph nodes were also sampled.The postoperative re-staging was ys-T4N0M0,stage ⅢA.Two cycles of gemcitabine combined with carboplatin was administered as the postoperative adjuvant chemotherapy.It takes 7.5 months from the first visit to the completion of treatment,and the follow-up was conducted every 3 months.No tumor recurrence was observed.Up to now,the progression-free survival and overall survival have been beyond 20 months.The diagnosis and treatment process suggests that MDT is of great significance for the treatment of stage Ⅲ superior sulcus NSCLC.